Artificial pancreas achieves glycaemic control in type 2 diabetes says study

The researchers concluded: “Among inpatients with type 2 diabetes receiving noncritical care, the use of an automated, closed-loop insulin-delivery system resulted in significantly better glycaemic control than conventional subcutaneous insulin therapy, without a higher risk of hypoglycaemia.”

To access the study, click here.

Leave a Reply

Your email address will not be published. Required fields are marked *